Insights into the cellular pharmacological properties of the BET-inhibitor OTX015/MK-8628 (birabresib), alone and in combination, in leukemia models

被引：8
|
作者：
Astorgues-Xerri, Lucile [1 ]
Vazquez, Ramiro [2 ]
Odore, Elodie [3 ]
Rezai, Keyvan [3 ]
Kahatt, Carmen [1 ]
Mackenzie, Sarah [1 ]
Bekradda, Mohamed [1 ]
Coude, Marie-Magdelaine [4 ]
Dombret, Herve [4 ]
Gardin, Claude [4 ]
Lokiec, Francois [3 ]
Raymond, Eric [5 ]
Noel, Kay [6 ]
Cvitkovic, Esteban [6 ]
Herait, Patrice [6 ]
Bertoni, Francesco [2 ]
Riveiro, Maria E. [1 ]
机构：
[1] Oncol Therapeut Dev, 100 Rue Martre, F-92110 Clichy, France
[2] Univ Svizzera Italiana, Inst Oncol Res, Bellinzona, Switzerland
[3] Rene Huguenin Hosp, Curie Inst, RadioPharmacol Dept, St Cloud, France
[4] Univ Paris Diderot, Lab Transfert Leucemies, Paris, France
[5] CHU Vaudois, Med Oncol Dept, Lausanne, Switzerland
[6] Oncoethix SA, Luzern, Switzerland
来源：
LEUKEMIA & LYMPHOMA | 2019年 / 60卷 / 12期
关键词：
OTX015; MK-8628; BROMODOMAIN; TARGETS;
D O I：
10.1080/10428194.2019.1617860
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3067 / 3070
页数：4
相关论文
共 15 条
  • [1] OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models
    Berenguer-Daize, Caroline
    Astorgues-Xerri, Lucile
    Odore, Elodie
    Cayol, Mylene
    Cvitkovic, Esteban
    Noel, Kay
    Bekradda, Mohamed
    MacKenzie, Sarah
    Rezai, Keyvan
    Lokiec, Francois
    Riveiro, Maria E.
    Ouafik, L'Houcine
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (09) : 2047 - 2055
  • [2] Activity of OTX015 (MK-8628), a BET-Bromodomain Inhibitor, in Acute Myeloid Leukemia (AML) Progenitor Cells
    Roulin, Louise
    Ali, Ashfaq
    Masse, Aline
    Coude, Marie-Magdelaine
    Bluteau, Dominique
    Braun, Thorsten
    Berrou, Jeanning
    Bluteau, Olivier
    Delord, Marc
    Riveiro, Maria Eugenia
    Herait, Patrice Edouard
    Soulier, Jean
    Baruchel, Andre
    Gardin, Claude
    Dombret, Herve
    Itzykson, Raphael
    [J]. BLOOD, 2015, 126 (23)
  • [3] Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts
    Vazquez, Ramiro
    Licandro, Simonetta Andrea
    Astorgues-Xerri, Lucile
    Lettera, Emanuele
    Panini, Nicolo
    Romano, Michela
    Erba, Eugenio
    Ubezio, Paolo
    Bello, Ezia
    Libener, Roberta
    Orecchia, Sara
    Grosso, Federica
    Riveiro, Maria Eugenia
    Cvitkovic, Esteban
    Bekradda, Mohamed
    D'Incalci, Maurizio
    Frapolli, Roberta
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (01) : 197 - 207
  • [4] 新起之秀，Birabresib(OTX015/MK-8628)通过抑制BET蛋白靶向治疗NUT癌等晚期实体瘤
    程婧
    吕镗烽
    [J]. 循证医学., 2024, 24 (05) - 275
  • [5] DOSE OPTIMIZATION OF MK-8628 (OTX015), A SMALL MOLECULE INHIBITOR OF BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEINS, IN PATIENTS WITH RECURRENT GLIOBLASTOMA
    Hottinger, A. F.
    Sanson, M.
    Moyal, E.
    Delord, J.
    Rezai, K.
    Leung, A.
    Perez, S.
    Bekradda, M.
    Lachaux, N.
    Chinot, O.
    [J]. NEURO-ONCOLOGY, 2016, 18 : 56 - 56
  • [6] Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma
    Gaudio, Eugenio
    Tarantelli, Chiara
    Ponzoni, Maurilio
    Odore, Elodie
    Rezai, Keyvan
    Bernasconi, Elena
    Cascione, Luciano
    Rinaldi, Andrea
    Stathis, Anastasios
    Riveiro, Eugenia
    Cvitkovic, Esteban
    Zucca, Emanuele
    Bertoni, Francesco
    [J]. ONCOTARGET, 2016, 7 (36) : 58142 - 58147
  • [7] The BET Inhibitor OTX015 (MK-8628) Shows in Vivo Antitumor Activity in Combination with Additional Targeted Agents in Diffuse Large B-Cell Lymphoma (DLBCL)
    Gaudio, Eugenio
    Cascione, Luciano
    Ponzoni, Maurilio
    Tarantelli, Chiara
    Bernasconi, Elena
    Riveiro, Maria Eugenia
    Cvitkovic, Esteban
    Zucca, Emanuele
    Bertoni, Francesco
    [J]. BLOOD, 2015, 126 (23)
  • [8] Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628
    Stathis, Anastasios
    Zucca, Emanuele
    Bekradda, Mohamed
    Gomez-Roca, Carlos
    Delord, Jean-Pierre
    Rouge, Thibault de La Motte
    Uro-Coste, Emmanuelle
    de Braud, Filippo
    Pelosi, Giuseppe
    French, Christopher A.
    [J]. CANCER DISCOVERY, 2016, 6 (05) : 492 - 500
  • [9] Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients (pts) with recurrent glioblastoma (GB)
    Hottinger, Andreas Felix
    Sanson, Marc
    Moyal, Elizabeth
    Delord, Jean-Pierre
    De Micheli, Rita
    Rezai, Keyvan
    Leung, Abraham C. F.
    Perez, Susan
    Bekradda, Mohamed
    Lachaux, Nicolas
    Lokiec, Francois Marc
    Chinot, Olivier L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus
    Vazquez, Ramiro
    Riveiro, Maria E.
    Astorgues-Xerri, Lucile
    Odore, Elodie
    Rezai, Keyvan
    Erba, Eugenio
    Panini, Nicolo
    Rinaldi, Andrea
    Kwee, Ivo
    Beltrame, Luca
    Bekradda, Mohamed
    Cvitkovic, Esteban
    Bertoni, Francesco
    Frapolli, Roberta
    D'Incalci, Maurizio
    [J]. ONCOTARGET, 2017, 8 (05) : 7598 - 7613
12